Annual report [Section 13 and 15(d), not S-K Item 405]

EQUITY - Schedule of Warrants (Details)

v3.26.1
EQUITY - Schedule of Warrants (Details) - USD ($)
$ / shares in Units, $ in Thousands
 1 Months Ended 12 Months Ended
Dec. 23, 2024
Feb. 28, 2025
Jul. 31, 2024
Feb. 29, 2024
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Derivative Warrants              
Warrants              
Balance at beginning of period (in shares)         21,400,000    
Balance at end of period (in shares)         21,400,000 21,400,000  
Warrants (derivative liabilities and equity)              
Warrants              
Balance at beginning of period (in shares)         71,918,536 86,931,558  
Granted (in shares)     19,400,000 1,800,000 8,710,626 21,900,000  
Cancelled/forfeited/expired (in shares) (35,862,922)       (1,235,075) (36,913,022)  
Balance at end of period (in shares)         79,394,087 71,918,536 86,931,558
Exercisable (in shares)         77,974,087    
Weighted - Average Exercise Price Per Warrant              
Balance at beginning of period (in dollars per share)         $ 1.03 $ 1.12  
Granted (in dollars per share)         0.48 0.99  
Cancelled/forfeited/expired (in dollars per share)         2.55 1.21  
Balance at end of period (in dollars per share)         0.95 $ 1.03 $ 1.12
Exercisable (in dollars per share)         $ 0.96    
Aggregate Intrinsic Value              
Outstanding         $ 2,019 $ 0 $ 0
Exercisable         $ 1,892    
Weighted Average Remaining Contractual Life (in Years)              
Outstanding         2 years 9 months 18 days 3 years 7 months 6 days 3 years
Exercisable         2 years 9 months 18 days    
Cancelled/forfeited/expired (in shares) 35,862,922       1,235,075 36,913,022  
Granted (in shares)   8,010,626 19,400,000        
Warrants (derivative liabilities and equity) | Non-Derivative Warrants              
Warrants              
Balance at beginning of period (in shares)         50,518,536 49,068,636  
Granted (in shares)         8,710,626 2,500,000  
Cancelled/forfeited/expired (in shares)         (1,235,075) (1,050,100)  
Balance at end of period (in shares)         57,994,087 50,518,536 49,068,636
Exercisable (in shares)         56,574,087    
Weighted Average Remaining Contractual Life (in Years)              
Cancelled/forfeited/expired (in shares)         1,235,075 1,050,100  
Warrants (derivative liabilities and equity) | Derivative Warrants              
Warrants              
Balance at beginning of period (in shares)         21,400,000 37,862,922  
Granted (in shares)         0 19,400,000  
Cancelled/forfeited/expired (in shares)         0 (35,862,922)  
Balance at end of period (in shares)         21,400,000 21,400,000 37,862,922
Exercisable (in shares)         21,400,000    
Weighted Average Remaining Contractual Life (in Years)              
Cancelled/forfeited/expired (in shares)         0 35,862,922